Brivaracetam population pharmacokinetics in children with epilepsy aged 1 month to 16 years

por Schoemaker, Rik, Wade, Janet R, Stockis, Armel
Publicado 2017

Extrapolation of a Brivaracetam Exposure–Response Model from Adults to Children with Focal Seizures

por Schoemaker, Rik, Wade, Janet R., Stockis, Armel
Publicado 2017

Basic PK/PD principles of drug effects in circular/proliferative systems for disease modelling

por Jacqmin, Philippe, McFadyen, Lynn, Wade, Janet R.
Publicado 2010

Population pharmacokinetic analysis of certolizumab pegol in patients with Crohn's disease

por Wade, Janet R., Parker, Gerry, Kosutic, Gordana, Feagen, Brian G., Sandborn, William J., Laveille, Christian, Oliver, Ruth
Publicado 2015

Changing Body Weight–Based Dosing to a Flat Dose for Avelumab in Metastatic Merkel Cell and Advanced Urothelial Carcinoma

por Novakovic, Ana M., Wilkins, Justin J., Dai, Haiqing, Wade, Janet R., Neuteboom, Berend, Brar, Satjit, Bello, Carlo L., Girard, Pascal, Khandelwal, Akash
Publicado 2019

Time‐Varying Clearance and Impact of Disease State on the Pharmacokinetics of Avelumab in Merkel Cell Carcinoma and Urothelial Carcinoma

por Wilkins, Justin J., Brockhaus, Brigitte, Dai, Haiqing, Vugmeyster, Yulia, White, Joleen T., Brar, Satjit, Bello, Carlo L., Neuteboom, Berend, Wade, Janet R., Girard, Pascal, Khandelwal, Akash
Publicado 2019

Characterization of exposure–response relationships of ipatasertib in patients with metastatic castration-resistant prostate cancer in the IPATential150 study

por Kotani, Naoki, Wilkins, Justin J., Wade, Janet R., Dang, Steve, Sutaria, Dhruvitkumar S., Yoshida, Kenta, Sundrani, Sameer, Ding, Hao, Garcia, Josep, Hinton, Heather, Sane, Rucha, Chanu, Pascal
Publicado 2022